Follow
Swarali S Kulkarni
Swarali S Kulkarni
Tessera Therapeutics
Verified email at tesseratx.com
Title
Cited by
Cited by
Year
High potency of a bivalent human VH domain in SARS-CoV-2 animal models
W Li, A Schäfer, SS Kulkarni, X Liu, DR Martinez, C Chen, Z Sun, SR Leist, ...
Cell 183 (2), 429-441. e16, 2020
1222020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
W Li, C Chen, A Drelich, DR Martinez, LE Gralinski, Z Sun, A Schäfer, ...
Proceedings of the National Academy of Sciences 117 (47), 29832-29838, 2020
882020
Unique aspects of adaptive immunity in camelids and their applications
SS Kulkarni, D Falzarano
Molecular Immunology 134, 102-108, 2021
62021
Immune Responses to MERS-CoV in Humans and Animals
NK Alharbi, SS Kulkarni, D Falzarano
Microbial Pathogenesis: Infection and Immunity, 85-97, 2021
22021
Neutralizing antibodies are associated with protection in animal models of coronavirus infection and vaccination.
SS Kulkarni
University of Saskatchewan, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–5